Skip to Main Content

4,497

Views

1

CrossRef citations to date

0

Altmetric

Perspective

Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines

Anthony M. Marchesea Medical Affairs, Novavax Inc, Gaithersburg, Maryland, USACorrespondence[email protected]
View further author information

,

Raj Kalkeric Clinical Immunology, Novavax Inc, Gaithersburg, Maryland, Gaithersburg, MarylandView further author information

,

Muruga Vadivaled Medical Affairs (APAC Region), Novavax Inc, Gaithersburg, Maryland, USAView further author information

,

Nungruthai Suntronwongb Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information

,

Seth Tobacka Medical Affairs, Novavax Inc, Gaithersburg, Maryland, USAView further author information

&

Yong Poovorawanb Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information